Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Shares of Ligand Pharmaceuticals (NASDAQ:LGND) were flat in pre-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share rose 112.24% year over year to $1.04, which beat the estimate of $0.98.
Revenue of $41,848,000 up by 68.69% from the same period last year, which missed the estimate of $44,360,000.
Outlook
The upcoming fiscal year's EPS expected to be between $6.00 and $6.00.
The upcoming fiscal year's revenue expected to be between $285,000,000 and $285,000,000.
Details Of The Call
Date: Oct 30, 2020
Time: 08:30 AM
ET Webcast URL: https://engage.vevent.com/index.jsp?eid=7772&seid=77#/main/simplify
Price Action
Company's 52-week high was at $127.80
52-week low: $57.24
Price action over last quarter: down 29.55%
Company Profile
Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!